IDMP Standards Explained: Importance and Benefits for Clinical Projects

This blog covers:

1. The importance of IDMP standards in clinical projects.
2. The key advantages of IDMP standards.

Introduction

In today’s evolving regulatory landscape, the Identification of Medicinal Products (IDMP) standards play a critical role in enabling structured and consistent electronic exchange of medicinal product data with regulatory authorities. As global pharmacovigilance systems move toward standardized data models, IDMP has become essential for ensuring accuracy, traceability, and interoperability across regions.

Building on our previous overview of IDMP standards, this article focuses on the key components and concepts used to accurately identify and characterize medicinal products.

Core Components in Identifying Medicinal Products

The identification and characterization of a medicinal product under IDMP are based on several structured components:

• Medicinal Product Name – The authorized name approved by the regional regulatory authority
• Clinical Particulars – Key medical information, including indications and contraindications
• Pharmaceutical Product Details – Active substances, dosage form, and route of administration
• Packaged Medicinal Product – Packaging configurations, containers, and product composition
• Marketing Authorization – Regulatory approval details, including authorization and licensing numbers
• Manufacturer / Establishment – Information on manufacturers, sites, and operations performed
• Versioning – Control and tracking of regulated product information across different regions

Benefits of IDMP

The implementation of IDMP standards offers several key advantages across pharmacovigilance and regulatory processes:

Enhanced Safety Surveillance

• Enables unambiguous global identification of medicinal products, improving accuracy in Individual Case Safety Reports (ICSRs)
• Facilitates global detection of safety signals associated with specific products reported in adverse events

Improved Transparency

• Supports global communication of medicinal product data across stakeholders
• Enhances trust and confidence among regulators, healthcare professionals, and the public regarding product quality and safety
• Promotes standardized identification of medicinal products through ISO IDMP frameworks

Mitigation of Drug Shortages

• Enables identification of pharmaceutically equivalent products across regions
• Supports regulatory and supply chain decisions to manage and mitigate drug shortages effectively

Interoperability

• Provides a harmonized and standardized data structure using globally consistent vocabularies
• Facilitates seamless exchange of medicinal product information between companies and regulatory authorities

Note:

Until fully harmonized controlled vocabularies for ISO IDMP are established, interim rules and region-specific identifiers may be used. These temporary measures ensure continuity in data exchange until global standardization is fully implemented.

Key takeaways

• IDMP is a set of internationally recognized ISO standards for the identification of medicinal products.
• Developed in collaboration with ICH and ISO, IDMP aims to enhance the structured exchange of medicinal product information across regulatory systems.
• IDMP standards play a critical role in E2B(R3) by supporting consistent and accurate data exchange in pharmacovigilance.
• These standards incorporate globally accepted elements such as ISO country codes and language codes to ensure harmonization.

Conclusion

IDMP represents a significant step toward global standardization in the identification and exchange of medicinal product data. By enabling consistent, structured, and interoperable information sharing, it strengthens pharmacovigilance activities and supports regulatory decision-making across regions.

As the industry continues to adopt IDMP, it will play an increasingly vital role in improving data quality, enhancing transparency, and ultimately safeguarding patient safety worldwide.